SXTC (China SXT Pharmaceuticals) EV-to-EBITDA : 2.58 (As of May. 23, 2025)

China SXT Pharmaceuticals EV-to-EBITDA Chart

China SXT Pharmaceuticals Semi-Annual Data
	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
EV-to-EBITDA	Get a 7-Day Free Trial											-	1.99	-	2.42	-

Competitive Comparison of China SXT Pharmaceuticals's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, China SXT Pharmaceuticals's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

China SXT Pharmaceuticals's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China SXT Pharmaceuticals's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where China SXT Pharmaceuticals's EV-to-EBITDA falls into.

China SXT Pharmaceuticals EV-to-EBITDA Calculation

China SXT Pharmaceuticals's EV-to-EBITDA for today is calculated as:

China SXT Pharmaceuticals's current Enterprise Value is $16.38 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. China SXT Pharmaceuticals's EBITDA for the trailing twelve months (TTM) ended in Sep. 2024 was $6.35 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China SXT Pharmaceuticals  (NAS:SXTC) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

China SXT Pharmaceuticals's PE Ratio (TTM) for today is calculated as:

China SXT Pharmaceuticals's share price for today is $1.65.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. China SXT Pharmaceuticals's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was $22.151.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?

China SXT Pharmaceuticals EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of China SXT Pharmaceuticals's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

China SXT Pharmaceuticals Business Description